Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Thrombocytopenia”

91 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 91 results

Not applicableStudy completedNCT05613296
What this trial is testing

Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP

Who this might be right for
ITP - Immune ThrombocytopeniaChronic ITPRefractory ITP
Gruppo Italiano Malattie EMatologiche dell'Adulto 95
Early research (Phase 1)Not Yet RecruitingNCT07599280
What this trial is testing

Universal STAR-T Cell Injection in R/R Autoimmune Diseases.

Who this might be right for
Immune Thrombocytopenia
Jian Zhu 6
Early research (Phase 1)Not Yet RecruitingNCT07490275
What this trial is testing

Allogeneic CD19/BCMA-Targeted CAR-γδT Cell Therapy: Safety and Preliminary Pharmacodynamics in Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Refractory/Relapsed Systemic Lupus ErythematosusRefractory / Relapsed / Progressive Systemic SclerosisRefractory / Relapsing / Progressive Inflammatory Myopathy+2 more
Institute of Hematology & Blood Diseases Hospital, China
Testing effectiveness (Phase 2)UnknownNCT00531089
What this trial is testing

Rituximab in Patients With Relapsed or Refractory TTP-HUS

Who this might be right for
Thrombotic Thrombocytopenic PurpuraHemolytic Uremic Syndrome
Hamilton Health Sciences Corporation 60
Not applicableStudy completedNCT04014166
What this trial is testing

Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia

Who this might be right for
ThrombocytopeniaMesenchymal Stem Cells
Institute of Hematology & Blood Diseases Hospital, China 18
Testing effectiveness (Phase 2)Study completedNCT02094417
What this trial is testing

Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia

Who this might be right for
Aplastic Anemia
Kyowa Kirin Korea Co., Ltd. 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07738822
What this trial is testing

A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA

Who this might be right for
Immune Thrombocytopenia (ITP)Warm Autoimmune Hemolytic Anemia (WAIHA)
Cullinan Therapeutics Inc. 72
Early research (Phase 1)Study completedNCT00001630
What this trial is testing

Treatment of Autoimmune Thrombocytopenia (AITP)

Who this might be right for
Autoimmune DiseaseAutoimmune Hemolytic AnemiaThrombocytopenia
National Heart, Lung, and Blood Institute (NHLBI) 29
Testing effectiveness (Phase 2)Study completedNCT03838354
What this trial is testing

A Clinical Trial of Chidamide in the Management of Refractory ITP

Who this might be right for
Thrombocytopenia
Shandong University 61
Large-scale testing (Phase 3)Study completedNCT00039910
What this trial is testing

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Who this might be right for
Non-Hodgkin LymphomaHodgkin DiseaseThrombocytopenia
Pfizer 240
Early research (Phase 1)Study completedNCT00003597
What this trial is testing

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

Who this might be right for
Cancer
Children's Oncology Group 16
Testing effectiveness (Phase 2)Looking for participantsNCT06794008
What this trial is testing

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusInflammatory MyopathySystemic Sclerosis (SSc)+6 more
Peking University People's Hospital 50
Not applicableStudy completedNCT00244010
What this trial is testing

Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias

Who this might be right for
Anemia, AplasticAmegakaryocytic ThrombocytopeniaDiamond-Blackfan Anemia+1 more
St. Jude Children's Research Hospital 4
Not applicableStudy completedNCT02922543
What this trial is testing

A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use

Who this might be right for
Multiple Myeloma
Celgene 361
Testing effectiveness (Phase 2)Study completedNCT01667263
What this trial is testing

The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia

Who this might be right for
Autoimmune Thrombocytopenia
Peking University People's Hospital 130
Testing effectiveness (Phase 2)Looking for participantsNCT07549698
What this trial is testing

Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease

Who this might be right for
Warm Autoimmune Hemolytic Anemia (WAIHA)ITP - Immune ThrombocytopeniaWarm Autoimmune Hemolytic Anemia+1 more
CRISPR Therapeutics AG 60
Testing effectiveness (Phase 2)Study completedNCT04083014
What this trial is testing

Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic AnemiaAutoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia
Peking Union Medical College Hospital 33
Testing effectiveness (Phase 2)Looking for participantsNCT07175493
What this trial is testing

CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia

Who this might be right for
Autoimmune CytopeniaImmune Thrombocytopenia (ITP)Autoimmune Hemolytic Anemia+1 more
Keymed Biosciences Co.Ltd 158
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Testing effectiveness (Phase 2)UnknownNCT03304288
What this trial is testing

The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 168
Next Page
9